# Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

> **NCT04069468** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 1247 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DEVICE:** TheraSphere

## Key facts

- **NCT ID:** NCT04069468
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 1247 (ACTUAL)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069468, "Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04069468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*